Genetic loci associated with prevalent and incident myocardial infarction and coronary heart disease in the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium
Authors:
- Julie HahnJHJulie Hahn
- Yi-Ping FuYFYi-Ping Fu
- Michael R. BrownMBMichael R. Brown
- Joshua C. BisJBJoshua C. Bis
- Paul S. de VriesPVPaul S. de Vries
- Mary F. FeitosaMFMary F. Feitosa
- Lisa R. YanekLYLisa R. Yanek
- Stefan WeissSWStefan Weiss
- Franco GiulianiniFGFranco Giulianini
- Albert Vernon SmithASAlbert Vernon Smith
- Xiuqing GuoXGXiuqing Guo
- Traci M. BartzTBTraci M. Bartz
Preprint
Abstract
Background Genome-wide association studies have identified multiple genomic loci associated with coronary artery disease, but most are common variants in non-coding regions that provide limited information on causal genes and etiology of the disease. To better understand etiological pathways that might lead to discovery of new treatments or prevention strategies, we focused our investigation on low-frequency and rare sequence variations primarily residing in coding regions of the genome while also exploring associations with common variants. Methods and Results Using samples of individuals of European ancestry from ten cohorts within the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium, both cross-sectional and prospective analyses were conducted to examine associations between genetic variants and myocardial infarction (MI), coronary heart disease (CHD), and all-cause mortality following these events. Single variant and gene-based analyses were performed separately in each cohort and then meta-analyzed for each outcome. A low-frequency intronic variant (rs988583) in PLCL1 was significantly associated with prevalent MI (OR=1.80, 95% confidence interval: 1.43, 2.27; P =7.12 × 10 -7 ). Three common variants, rs9349379 in PHACTR1 , and rs1333048 and rs4977574 in the 9p21 region, were significantly associated with prevalent CHD. Four common variants (rs4977574, rs10757278, rs1333049, and rs1333048) within the 9p21 locus were significantly associated with incident MI. We conducted gene-based burden tests for genes with a cumulative minor allele count (cMAC) 5 and variants with minor allele frequency (MAF) < 5%. TMPRSS5 and LDLRAD1 were significantly associated with prevalent MI and CHD, respectively, and RC3H2 and ANGPTL4 were significantly associated with incident MI and CHD, respectively. No loci were significantly associated with all-cause mortality following a MI or CHD event. Conclusion This study confirmed previously reported loci influencing heart disease risk, and one single variant and three genes associated with MI and CHD were newly identified and warrant future investigation.Keywords
All Related Versions
- Published version: PLOS ONE, 15 (11), e0230035.
This publication has 40 references indexed in Scilit:
- Best Practices and Joint Calling of the HumanExome BeadChip: The CHARGE ConsortiumPLOS ONE, 2013
- dbNSFP v2.0: A Database of Human Non-synonymous SNVs and Their Functional Predictions and AnnotationsHuman Mutation, 2013
- Genome-Wide Testing of Putative Functional Exonic Variants in Relationship with Breast and Prostate Cancer Risk in a Multiethnic PopulationPLOS Genetics, 2013
- Rare-Variant Association Testing for Sequencing Data with the Sequence Kernel Association TestThe American Journal of Human Genetics, 2011
- dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictionsHuman Mutation, 2011
- The Effect of Survival Bias on Case-Control Genetic Association Studies of Highly Lethal DiseasesCirculation: Cardiovascular Genetics, 2011
- METAL: fast and efficient meta-analysis of genomewide association scansBioinformatics, 2010
- Variation in ANGPTL4 and risk of coronary heart disease: the Atherosclerosis Risk in Communities StudyMetabolism, 2008
- Methods for Detecting Associations with Rare Variants for Common Diseases: Application to Analysis of Sequence DataThe American Journal of Human Genetics, 2008
- Sibling Cardiovascular Disease as a Risk Factor for Cardiovascular Disease in Middle-aged AdultsJAMA, 2005